Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Mérida, Venezuela

Medical Science Monitor

Volumn 13, Issue 4, 2007, Pages

  Salazar De Vegas, Elsa Zuleima ^a,b,e   Nieves, Beatriz ^b   Ruiz, Marc ^c   Ruíz, Joaquim ^d   Vila, Jordi ^c   María, Araque ^b   Elsa, Velázco ^b  

^a UNIVERSIDAD DE ORIENTE   (Venezuela)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e Parcelamiento Miranda   (Venezuela)

Author keywords

Acinetobacter; OXA 58; PFGE; Resistance

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; TETRACYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; HUMIDIFIER; INTENSIVE CARE UNIT; MOLECULAR EPIDEMIOLOGY; NEWBORN INTENSIVE CARE; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; VENEZUELA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; CIPROFLOXACIN; DISEASE OUTBREAKS; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENES, BACTERIAL; GENTAMICINS; HUMANS; IMIPENEM; INFANT, NEWBORN; TETRACYCLINES; VENEZUELA;

EID: 34147164449     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bergogne-Bérézin E, Towner K: Acinetobacter spp as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Res, 1996; 9: 148-65
2. Bou G, Cervero G, Dominguez MA et al: Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of b-Lactamases. J Clin Microbiol, 2000; 38: 3299-305
3. Nuñez ML, Martinez-Toldos MC, Bru M et al: Appearance of resistance to meropenem during the treatment of a patient with meningitis by Acinetobacter. Scand J Dis, 1998; 30: 421-23
4. Pandey A, Kapil A, Sood S et al: In vitro activities of ampicilin-sulbactam and amoxicilin-clavulanic acid against Acinetobacter baumannii. J Clin Microbiol, 1998; 36: 3415-16
5. Spence RP, Towner KJ, Henwood CJ et al: Population structure and antibiotic resistance of Acinetobacter DNA group 2 and 13TU isolates from hospitals in the UK. J Med Microbiol, 2002; 51: 1107-12
6. Vila J, Ribera A, Marco F et al: Activity of clinafloxacin, compared with other four quinolones, against Acinetobacter baumannii clinical isolates with known mechanisms of quinolone resistance. J Antimicrob Chemother, 2002; 49: 471-77
7. Bouvet P, Grimont P: Taxonomy of the Genus Acinetobacter with the Recognition of Acinetobacter baumannii sp. nov, Acinetobacter haemolyticus sp. nov. Acinetobacter johnsonii sp. nov. and Acinetobacter junii sp. nov. and Emended Descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int J Syst Bacteriol, 1986; 36: 228-40
8. Salazar de Vegas EZ, Nieves B, Araque M et al: Outbreak of Infection With Acinetobacter Strain RUH 1139 in an Intensive Care Unit. Infect Control Hosp Epidemiol, 2006; 27: 397-403
9. Tenover FC, Arbeit RD, Goering RV et al: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol, 1995; 33: 2233-39
10. th ed. Approved Standards M7-A6, Villanova. PA, USA. 2003
11. Jarlier V, Nicolas M, Fournier G, Philippon A: Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis, 1988; 10: 867-77
12. Mathew A, Harris AM, Marshall MJ, Ross GW: The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol, 1975; 88: 169-78
13. Danes C, Navia MM, Ruiz J et al: distribution of b-lactamases in Acinetobacter baumannii Clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different β-lactam antibiotics. J Antimicrob Chemother, 2002; 50: 261-64
14. Navia MM, Capitano L, Ruiz J et al: Typing and characterization of the mechanisms of resistance in Shigella sp. isolated from faeces of children in Ifakara (Tanzania). J Clin Microbiol, 1999; 37: 3113-17
15. Gallardo F, Ruiz J, Marco F et al: Increase in incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance. J Med Microbiol, 1999; 48: 367-74
16. Vila J, Navia M, Ruiz J, Casals C: Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived b-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother, 1997; 41: 2757-59
17. Ploy MC, Giamarellou H, Bourlioux P et al: Detection of aac(6′)-I genes in amikacin-resistant Acinetobacter spp. by PCR. Antimicrob Agent Chemother, 1994; 38: 2925-28
18. Vila J, Ruiz J, Navia M et al: Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol, 1999; 37: 758-61
19. Guardabassi L, Dijkshoorn L, Collard JM et al: Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic acinetobacter strains. J Med Microbiol, 2000; 49: 929-36
20. Ribera A, Ruiz J, Vila J: Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii. Antimicrob Agents Chemother, 2003; 47: 2310-12
21. Levesque C, Roy PH: PCR analysis of integrons. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic molecular microbiology: principles and applications. Washington, D.C.: American Society for Microbiology 1993; 590-94
22. Oteo J, Alós I: ¿Qué hay de nuevo en la resistencia bacteriana a los antimicrobianos? Enferm Infecc Microbiol Clín, 2002; 20: 28-33
23. Vila J: Mechanism of antimicrobial resistance in Acinetobacter baumannii. Rev Med Microbiol, 1998; 9: 87-97
24. Poirel L, Marque S, Heritier C et al: OXA-58, a novel class D b-lactamase involved in resistance to carbapenems in Acinetobacter baumannii Antimicrob Agents Chemother, 2005; 49: 202-8
25. Heritier C, Dubouix A, Poirel L et al: A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J Antimicrob Chemother, 2005; 55: 115-18
26. Marqué S, Poirel L, Héritier C et al: Regional Occurrence of Plasmid-Mediated Carbapenem-Hydrolyzing Oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol, 2005; 43(9): 4885-88
27. Coelho J, Woodford N, Afzal-Shah M, Livermore D: Occurrence of OXA-58-Like carbapenemases in Acinetobacter spp. Collected over 10 Years in three Continents. Antimicrob. Agents Chemother, 2006; 50(2): 756-58
28. Peleg AY, Franklin C, Walter LJ et al: OXA-58 and IMP-4 Carbapenem-Hydrolyzing b-lactamases in an Acinetobacter junii Blood Culture Isolate from Australia. Antimicrob. Agents Chemother, 2006; 50: 399-400
29. Pournaras S, Markogiannakis A, Ikonomidis A et al: Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemases in an intensive care unit. J. Antimicrob. Chemother, 2006; 57: 557-61
30. Vahaboglu H, Budak F, Kasap M: High prevalence of OXA-51-type class D b-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centers. J. Antimicrob. Chemother, 2006; 58: 537-42
31. Navia MM, Ruiz J, Vila J: Dispersión intercontinental de una cepa de Shigella flexneri resistente a trimetoprim. Enferm Infecc Microbiol Clín, 2003; 21: 401-3
32. Magnet S, Courvalin P, Lambert T: Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother, 2001; 45: 3375-80
33. Navia MM, Ruíz J, Vila J: Characterization of an integron carrying a new class D β-lactamase (OXA-37) in Acinetobacter baumannii. Microb Drug Resist, 2002; 8: 261-65
34. Ribera A, Vila J, Fernandez-Cuenca F et al: Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals. Antimicrob Agents Chemother, 2004; 48: 364-65
35. Ruiz J, Navia MM, Casals C et al: Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain. Clin Microbiol Infect, 2003; 9: 907-11
36. Seward RJ, Towner KJ: Detection of integrons in worldwide nosocomial isolates of Acinetobacter spp. Clin Microbiol Infect, 1999; 5: 308-18
37. Towner KJ: Plasmid and transposon behaviour in Acinetobacter. In: Towner KJ, Bergogne-Bérézin E, Fewson CA, eds. The biology of Acinetobacter. New York: Plenum Publishing Corp., 1991; 149-67
38. Collis CM, Grammaticopoulos G, Briton J et al: Site-specific insertion of gene cassettes into integrons. Mol Microbiol, 1993; 9: 41-52
39. Huys G, Cnockaert M, Vaneechoutte M: Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals. Res Microbiol, 2004; 156: 348-55